ClearPoint Neuro, Inc. (CLPT): Price and Financial Metrics
CLPT Price/Volume Stats
| Current price | $10.96 | 52-week high | $14.13 |
| Prev. close | $10.97 | 52-week low | $5.11 |
| Day low | $10.60 | Volume | 147,900 |
| Day high | $11.05 | Avg. volume | 188,924 |
| 50-day MA | $11.94 | Dividend yield | N/A |
| 200-day MA | $8.35 | Market Cap | 302.33M |
CLPT Stock Price Chart Interactive Chart >
ClearPoint Neuro, Inc. (CLPT) Company Bio
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.
CLPT Price Returns
| 1-mo | -14.31% |
| 3-mo | -7.74% |
| 6-mo | 86.71% |
| 1-year | 87.03% |
| 3-year | -20.17% |
| 5-year | 194.62% |
| YTD | 61.41% |
| 2023 | -19.83% |
| 2022 | -24.51% |
| 2021 | -29.39% |
| 2020 | 231.04% |
| 2019 | 205.73% |
Loading social stream, please wait...